Add like
Add dislike
Add to saved papers

Impacts of complete endophytic renal tumors on surgical, functional, and oncological outcomes of robot-assisted partial nephrectomy.

Journal of Endourology 2024 January 21
OBJECTIVE: Complete endophytic renal tumors (CERTs) are the most challenging for robot-assisted partial nephrectomy (RAPN). This study aimed to determine the impact of CERT on outcomes of RAPN.

METHODS: All RAPN cases for localized renal tumor undertaken at Yokohama City University Hospital between 2016 and 2023, were enrolled. Tumor characteristics and surgical, functional, and oncologic outcomes of RAPN were compared between CERT and non-CERT groups.

RESULTS: Consecutive 666 patients were enrolled, and 76 (11.4%) were identified as CERT (3 points of "E" score). CERT showed smaller tumor diameters (P<0.001), more predominant hilar tumor (P=0.029), higher "N" scores (P<0.001) and "L" scores (P=0.006) than non-CERT. The CERT group showed longer warm ischemia times (P<0.001), more frequent positive surgical margins (P=0.028), and relatively lower trifecta achievement rates (P=0.101) than the non-CERT group. In multivariable analysis, the CERT was an independent predictor for trifecta achievement but not for pentafecta achievement.

CONCLUSIONS: CERT was associated with longer warm ischemia time, positive surgical margin, and lower trifecta achievement, but not with surgical complication and pentafecta achievement in RAPN. This study suggested that CERT had limited influence on long-term renal functional preservation, however, had strong impacts on short-term surgical outcome.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app